Proceedings of the American Thoracic Society Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rabe, K. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rabe, K. F.
The Proceedings of the American Thoracic Society 3:270-275 (2006)
© 2006 The American Thoracic Society

Improving Dyspnea in Chronic Obstructive Pulmonary Disease

Optimal Treatment Strategies

Klaus F. Rabe

Leiden University Medical Center, Department of Pulmonology, Leiden, The Netherlands

Correspondence and requests for reprints should be addressed to Prof. Dr. K.F. Rabe, M.D., Ph.D., Department of Pulmonology, C3-P16, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands. E-mail: k.f.rabe{at}lumc.nl

ABSTRACT

Chronic obstructive pulmonary disease (COPD) is a common disease with a global impact in terms of morbidity and mortality. Patients usually consult their doctor because of symptoms, and among those, dyspnea at rest or under exercise is one of the most common. The sensation of dyspnea is experienced differently among individuals with COPD and may be based on diverse factors, such as muscle fatigue, patient perception, or trapped volumes. Treatment algorithms for COPD emphasize a stepwise approach to therapy depending on the severity of the disease, which, for reasons of convenience, is primarily based on spirometric impairment. Drugs that alter bronchial smooth muscle tone and increase inspiratory capacity have clinical efficacy for the dyspneic patient, most likely based on their effect on lung function, whereas the effects of antiinflammatory therapy with inhaled corticosteroids is more difficult to explain. The following short review aims to give an overview of the available clinical information of clinical trials performed over the last couple of years.

Key Words: chronic respiratory disease, outcomes • chronic respiratory disease, pharmacotherapy




This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
M. I.M. Versteegh, J. Braun, P. G. Voigt, D. B. Bosman, J. Stolk, K. F. Rabe, and R. A.E. Dion
Diaphragm plication in adult patients with diaphragm paralysis leads to long-term improvement of pulmonary function and level of dyspnea
Eur. J. Cardiothorac. Surg., September 1, 2007; 32(3): 449 - 456.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Thoracic Society.